Thoratec cheered by US authority's appraisal of LVAD (left ventricular assist devices)
This article was originally published in Clinica
Executive Summary
Left ventricular assist devices (LVADs) provide a "substantially more effective" net outcome for patients with end stage heart failure than drugs alone, a government advisory committee concluded this week. Their appraisal ranks the technology as second only to breakthrough technology.